Somatuline Autogel

Somatuline Autogel Description

lanreotide

Manufacturer:

Ipsen Pharma

Distributor:

Zuellig Pharma
Full Prescribing Info
Description
Somatuline Autogel 60 mg, 90 mg and 120 mg is a prolonged-release solution for injection in a pre-filled syringe containing 60 mg, 90 mg and 120 mg of lanreotide acetate respectively.
Somatuline Autogel 60 mg: Each pre-filled syringe contains a supersaturated solution of lanreotide acetate corresponding to 0.246 mg of lanreotide base/mg of solution, which ensures an actual injection dose of 60 mg.
Somatuline Autogel 90 mg: Each pre-filled syringe contains a supersaturated solution of lanreotide acetate corresponding to 0.246 mg of lanreotide base/mg of solution, which ensures an actual injection dose of 90 mg.
Somatuline Autogel 120 mg: Each pre-filled syringe contains a supersaturated solution of lanreotide acetate corresponding to 0.246 mg of lanreotide base/mg of solution, which ensures an actual injection dose of 120 mg.
Excipients/Inactive Ingredients: Water for injections, acetic acid (for pH adjustment).
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in